Advanced search
Publication Cover
Clinical Epidemiology Volume 9, 2017 - Issue
Submit an article Journal homepage
144
Views
30
CrossRef citations to date
0
Altmetric
Original Research

Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes

Jason C Simeone1 Real-world Evidence, Evidera, Waltham, MA, USACorrespondence[email protected]
,
Jay P Bae2 Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Indianapolis, IN, USA
,
Byron J Hoogwerf3 Lily Diabetes, Eli Lilly and Company, Indianapolis, IN, USA
,
Qian Li1 Real-world Evidence, Evidera, Waltham, MA, USA
,
Axel Haupt3 Lily Diabetes, Eli Lilly and Company, Indianapolis, IN, USA
,
Ayad K Ali4 Global Patient Safety, Eli Lilly and Company, Indianapolis, IN, USA
,
Marilyn K Boardman3 Lily Diabetes, Eli Lilly and Company, Indianapolis, IN, USA
&
Beth L Nordstrom1 Real-world Evidence, Evidera, Waltham, MA, USA
 show all
Pages 679-688 | Published online: 14 Dec 2017

References

  • YounossiZMStepanovaMAfendyMChanges in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008Clin Gastroenterol Hepatol201196524530 e521 quiz e56021440669
  • VernonGBaranovaAYounossiZMSystematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adultsAliment Pharmacol Ther201134327428521623852
  • Neuschwander-TetriBACaldwellSHNonalcoholic steatohepatitis: summary of an AASLD single topic conferenceHepatology20033751202121912717402
  • AnguloPHuiJMMarchesiniGThe NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLDHepatology200745484685417393509
  • McPhersonSStewartSFHendersonEBurtADDayCPSimple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver diseaseGut20105991265126920801772
  • WaiCTGreensonJKFontanaRJA simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis CHepatology200338251852612883497
  • BhalaNAnguloPvan der PoortenDThe natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative studyHepatology20115441208121621688282
  • EkstedtMHagstromHNasrPFibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-upHepatology20156151547155425125077
  • HamaguchiMKojimaTTakedaNThe metabolic syndrome as a predictor of nonalcoholic fatty liver diseaseAnn Intern Med20051431072272816287793
  • JakobsenMUBerentzenTSørensenTIOvervadKAbdominal obesity and fatty liverEpidemiol Rev2007291778717478441
  • MussoGGambinoRCassaderMPaganoGMeta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severityAnn Med201143861764921039302
  • WilliamsKHShackelNAGorrellMDMcLennanSVTwiggSMDiabetes and nonalcoholic fatty liver disease: a pathogenic duoEndocr Rev20133418412923238855
  • LoriaPLonardoAAnaniaFLiver and diabetes. A vicious circleHepatol Res2013431516423332087
  • LinZHXinYNDongQJPerformance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysisHepatology201153372673621319189
  • SterlingRKLissenEClumeckNAPRICOT Clinical InvestigatorsDevelopment of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology20064361317132516729309
  • KamathPSKimWRAdvanced Liver Disease Study GroupThe model for end-stage liver disease (MELD)Hepatology200745379780517326206
  • KimBKKimDYParkJYValidation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patientsLiver Int201030454655320074094
  • van MontfortKOudJGhideyWDevelopments in Statistical Evaluation of Clinical TrialsNew York, NYSpringer-Verlag Berlin Heidelberg2014
  • JacksonCMulti-state modelling with R: the msm package. Original version 2007 Available from: https://www.researchgate.net/publication/228628174_Multi-state_modelling_with_R_the_msm_packageAccessed June 1, 2017
  • JacksonCMulti-state modelling with R: the msm package. Version 1.6.4 [updated 2 October 2016] Available from: https://cran.r-project.org/web/packages/msm/vignettes/msm-manual.pdfAccessed June 1, 2017
  • JacksonCHMulti-state models for panel data: the msm package for RJ Stat Softw2011388129
  • SinghSAllenAMWangZProkopLJMuradMHLoombaRFibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studiesClin Gastroenterol Hepatol2015134643654e641649 quiz e639–64024768810
  • HagstromHNasrPEkstedtMSAF score and mortality in NAFLD after up to 41 years of follow-upScand J Gastroenterol2017521879127616339
  • AnguloPKleinerDEDam-LarsenSLiver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver diseaseGastroenterology20151492389397 e31025935633
  • American Diabetes AssociationStandards of medical care in diabetes-2016 abridged for primary care providersClin Diabetes201634132126807004
  • European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of ObesityEASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver diseaseJ Hepatol20166461388140227062661

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.